Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.03.2002 | Main Topics: Biotechnology In Vascular Surgery

Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity

verfasst von: Alicja Jozkowicz, Ph.D., J. Dulak, Anneliese Nigisch, G. Weigel, E. Sporn, A. Fügl, I. Huk

Erschienen in: European Surgery | Ausgabe 2/2002

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Role of peroxisome proliferator-activated receptorγ ligands in the vessel wall

Nächster Artikel Tolerance induction through mixed chimerism

Titel: Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity
verfasst von: Alicja Jozkowicz, Ph.D.
J. Dulak
Anneliese Nigisch
G. Weigel
E. Sporn
A. Fügl
I. Huk
Publikationsdatum: 01.03.2002
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 2/2002
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1046/j.1563-2563.2002.02024.x

Weitere Artikel der Ausgabe 2/2002

Role of peroxisome proliferator-activated receptorγ ligands in the vessel wall

Main Topics: Biotechnology In Vascular Surgery

Invited commentary to: ‘Virtual dissection and automated polyp detection of the colon based on spiral CT — Techniques and preliminary experience on a cadaveric phantom’ (Eur. Surg. 2002;34:143–149)

Original Scientific Papers

Tolerance induction through mixed chimerism

Review

Ischaemia/reperfusion injury of skeletal muscle: Mechanisms, morphology, treatment strategies, and clinical applications

Main Topics: Biotechnology In Vascular Surgery

Closing remarks

Original Scientific Papers

Congress Announcement